0001728787-26-000001.txt : 20260123 0001728787-26-000001.hdr.sgml : 20260123 20260123140102 ACCESSION NUMBER: 0001728787-26-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20260123 DATE AS OF CHANGE: 20260123 EFFECTIVENESS DATE: 20260123 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ikarian Healthcare Offshore Fund, Ltd. CENTRAL INDEX KEY: 0001728787 ORGANIZATION NAME: EIN: 981400036 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-303780 FILM NUMBER: 26555596 BUSINESS ADDRESS: STREET 1: 100 CRESCENT COURT STREET 2: SUITE 1620 CITY: DALLAS STATE: TX ZIP: 75201 BUSINESS PHONE: (214) 276-0670 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: C/O MAPLES CORPORATE SERVICES LIMITED STREET 2: PO BOX 309, UGLAND HOUSE CITY: GRAND CAYMAN NON US STATE TERRITORY: CAYMAN ISLANDS PROVINCE COUNTRY: E9 D/A 1 primary_doc.xml X0708 D/A LIVE 0001728787 Ikarian Healthcare Offshore Fund, Ltd. 100 CRESCENT COURT SUITE 1620 DALLAS TX TEXAS 75201 (214) 276-0670 CAYMAN ISLANDS None None Other Cayman Islands Exempted Company true Neil Shahrestani 100 Crescent Court Suite 1620 DALLAS TX TEXAS 75201 Executive Officer Manager of the Investment Manager of the Issuer N/A Ikarian Capital, LLC 100 Crescent Court Suite 1620 DALLAS TX TEXAS 75201 Executive Officer Investment Manager of the Issuer Sophia Dilbert Suite 5B201, 2nd Floor, One Nexus Way P.O. Box 2587 Camana Bay, Grand Cayman E9 CAYMAN ISLANDS KY1 1103 Director Joe Hardiman 521 Brighton Avenue Spring Lake NJ NEW JERSEY 07762 Director Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.7 true 0001728787-25-000001 2018-02-01 true true true false 100000 Indefinite 217456216 Indefinite false 102 0 0 0 Investment Manager is entitled to a management fee. An affiliate of the Investment Manager is entitled to a performance allocation. Such fee and allocation terms are fully disclosed in the confidential offering materials of the Issuer. false Ikarian Healthcare Offshore Fund, Ltd. Troy Wuertz Troy Wuertz Chief Compliance Officer of the Investment Manager 2026-01-23